E

ENCell Co Ltd
KOSDAQ:456070

Watchlist Manager
ENCell Co Ltd
KOSDAQ:456070
Watchlist
Price: 14 410 KRW -6.12%
Market Cap: 153.5B KRW
Have any thoughts about
ENCell Co Ltd?
Write Note

ENCell Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ENCell Co Ltd
Capital Expenditures Peer Comparison

Comparables:
207940
S
237690
F
220100
L
141080
C
268600

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
E
ENCell Co Ltd
KOSDAQ:456070
Capital Expenditures
-â‚©1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Capital Expenditures
-â‚©692.9B
CAGR 3-Years
-30%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Capital Expenditures
-â‚©45.7B
CAGR 3-Years
-8%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Capital Expenditures
-â‚©2.3B
CAGR 3-Years
26%
CAGR 5-Years
25%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Capital Expenditures
-â‚©2.2B
CAGR 3-Years
35%
CAGR 5-Years
8%
CAGR 10-Years
-16%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Capital Expenditures
-â‚©1.6m
CAGR 3-Years
90%
CAGR 5-Years
73%
CAGR 10-Years
N/A

See Also

What is ENCell Co Ltd's Capital Expenditures?
Capital Expenditures
-1.9B KRW

Based on the financial report for Dec 31, 2023, ENCell Co Ltd's Capital Expenditures amounts to -1.9B KRW.

What is ENCell Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
55%

Over the last year, the Capital Expenditures growth was 55%.

Back to Top